Company news

Arovella Therapeutics Limited news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

NovaDel Shareholders Approve Suda Acquisition of Assets

February 10, 2016

Non-Renounceable Issue

February 10, 2016

MIA strong earnings performance after takeover

February 10, 2016

Manufacturing Update

February 10, 2016

Management and board restructure

February 10, 2016

Malaria trial - patient dosing commenced

February 10, 2016

Malaria Treatment Update

February 10, 2016

Issue of Secured Convertible Notes

February 10, 2016

HC Berlin Pharma moves to secure E42 million finance package

February 10, 2016

Half Yearly Report/Half Year Accounts

February 10, 2016

Half Yearly Report & Half Year Accounts

February 10, 2016

Half Year Accounts

February 10, 2016

Gets Green Light on P.A.P. Technology Global Patents

February 10, 2016

Funding Approval for Sth African Acquisition

February 10, 2016

Field trials completed

February 10, 2016

Expands Australian Distribution Network

February 10, 2016

EMS Share Purchase Plan Offer

February 10, 2016

Eastland update

February 10, 2016

Eastland to issue new convertible notes

February 10, 2016

Eastland`s subsidiary wins first tender valued at $2.5m

February 10, 2016

Eastlands phase iii clinical trial update

February 10, 2016

Eastland Realises $2.5 million from its IMD Shareholding

February 10, 2016

Eastland moves to acquire 90% of Star Medical Botswana

February 10, 2016

Eastland in First Step to African Funding

February 10, 2016

Eastland Increases Stake In Star Medical Botswana

February 10, 2016

Eastland clinical trial update

February 10, 2016

Eastland Associate acquires UK Medical Distributor

February 10, 2016

Eastland accepts unconditional offer for mia

February 10, 2016

Eastland accepts unconditional offer

February 10, 2016

Corporate governance review

February 10, 2016

Continues Global Expansion

February 10, 2016

Confirms Westcoast Surgical acquisition now unconditional

February 10, 2016

Company Update

February 10, 2016

Commitments Test Entity - Second Quarter Report

February 10, 2016

Commitments Test Entity - First Quarter Report

February 10, 2016

Commences production of Safe Veterinary Needle

February 10, 2016

Clinican Trial Results Presented at ICAAC in Boston USA

February 10, 2016

Clinical trial update

February 10, 2016

Clinical Trial Update

February 10, 2016

Chairman`s Address to Shareholders

February 10, 2016

Bergen Funding Postponed

February 10, 2016

ArTiMist Manufacturing Update

February 10, 2016

Approval to commence clinical trial

February 10, 2016

Approval for South African multi dose phase 1 clinical trial

February 10, 2016

Appendix 4D Half Year Ended 31 December 2014

February 10, 2016

Appendix 4D Half Year Ended 31 December 2012

February 10, 2016

Appendix 4C - monthly

February 10, 2016

Anti-Malaria Progress for Eastland

February 10, 2016

← Newer news releases

Decks

The 5 newest of 45 decks. Every deck is listed under its year.